141 related articles for article (PubMed ID: 16309363)
1. Protein profiling as a diagnostic tool in clinical chemistry: a review.
Bons JA; Wodzig WK; van Dieijen-Visser MP
Clin Chem Lab Med; 2005; 43(12):1281-90. PubMed ID: 16309363
[TBL] [Abstract][Full Text] [Related]
2. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W
BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602
[TBL] [Abstract][Full Text] [Related]
3. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
4. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
Semmes OJ; Feng Z; Adam BL; Banez LL; Bigbee WL; Campos D; Cazares LH; Chan DW; Grizzle WE; Izbicka E; Kagan J; Malik G; McLerran D; Moul JW; Partin A; Prasanna P; Rosenzweig J; Sokoll LJ; Srivastava S; Srivastava S; Thompson I; Welsh MJ; White N; Winget M; Yasui Y; Zhang Z; Zhu L
Clin Chem; 2005 Jan; 51(1):102-12. PubMed ID: 15613711
[TBL] [Abstract][Full Text] [Related]
6. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
7. The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.
Cadron I; Van Gorp T; Amant F; Vergote I; Moerman P; Waelkens E; Daemen A; Van De Plas R; De Moor B; Zeillinger R
Anticancer Res; 2009 Apr; 29(4):1039-45. PubMed ID: 19414343
[TBL] [Abstract][Full Text] [Related]
8. ProteoMiner™ and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum.
Fröbel J; Hartwig S; Passlack W; Eckel J; Haas R; Czibere A; Lehr S
Arch Physiol Biochem; 2010; 116(4-5):174-80. PubMed ID: 20662595
[TBL] [Abstract][Full Text] [Related]
9. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
[TBL] [Abstract][Full Text] [Related]
11. MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers.
Cazares LH; Diaz JI; Drake RR; Semmes OJ
Methods Mol Biol; 2008; 428():125-40. PubMed ID: 18287771
[TBL] [Abstract][Full Text] [Related]
12. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.
Schaub S; Wilkins J; Weiler T; Sangster K; Rush D; Nickerson P
Kidney Int; 2004 Jan; 65(1):323-32. PubMed ID: 14675066
[TBL] [Abstract][Full Text] [Related]
13. Biomarker discovery using SELDI-TOF protein chip technology.
Lehr S
Arch Physiol Biochem; 2010; 116(4-5):157. PubMed ID: 20839924
[No Abstract] [Full Text] [Related]
14. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
15. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology].
Guan X; Li DR; Wang Q; Li L; Ruan HY; Zhang W
Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445
[TBL] [Abstract][Full Text] [Related]
16. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
[TBL] [Abstract][Full Text] [Related]
17. Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer.
Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; Yang BX; He DC; Zhao XJ
Asian J Androl; 2006 Jan; 8(1):45-51. PubMed ID: 16372118
[TBL] [Abstract][Full Text] [Related]
18. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
19. SELDI-TOF MS profiling of plasma proteins in ovarian cancer.
Wu SP; Lin YW; Lai HC; Chu TY; Kuo YL; Liu HS
Taiwan J Obstet Gynecol; 2006 Mar; 45(1):26-32. PubMed ID: 17272204
[TBL] [Abstract][Full Text] [Related]
20. Optimized conditions for a quantitative SELDI TOF MS protein assay.
Lomas L; Clarke CH; Thulasiraman V; Fung E
Methods Mol Biol; 2012; 818():1-10. PubMed ID: 22083812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]